These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 4984667)
1. The metabolism of C14-ICI 54,450 (myalex) in various species--an in vivo NIH shift. Foulkes DM J Pharmacol Exp Ther; 1970 Mar; 172(1):115-21. PubMed ID: 4984667 [No Abstract] [Full Text] [Related]
2. Metabolic patterns of 4-allyloxy-3-chlorophenylacetic acid in rat, rabbit, dog, monkey, and man. Roncucci R; Simon MJ; Lambelin G; Gillet C; Staquet M; Buu-Hoï NP Arzneimittelforschung; 1970 May; 20(5):631-6. PubMed ID: 4987566 [No Abstract] [Full Text] [Related]
3. Absorption, distribution, excretion and metabolism of tiaramide hydrochloride: a new anti-inflammatory drug. Noda K; Noguchi H; Okui M; Tada K; Morimoto Y Arzneimittelforschung; 1972 Apr; 22(4):732-43. PubMed ID: 4626080 [No Abstract] [Full Text] [Related]
4. Absorption, excretion and metabolism of a new analgesic and anti-inflammatory drug K 4277 in rats, guinea pigs, rabbits and dogs. Goldaniga GC; Pianezzola E; Valzelli G Arzneimittelforschung; 1974 Oct; 24(10):1603-6. PubMed ID: 4479768 [No Abstract] [Full Text] [Related]
5. Metabolism and pharmacokinetics of a new nonsteroid, anti-inflammatory agent, 2-(3-chloro-o-toluidino) nicotinic acid (clonixin) in rats, dogs and monkeys. Katchen B; Buxbaum S; Meyer J; Ning J J Pharmacol Exp Ther; 1973 Feb; 184(2):453-64. PubMed ID: 4631713 [No Abstract] [Full Text] [Related]
6. Metabolism of 4-(3-(dimethylamino)propyl)-3,4-dihydro-2-(1-hydroxyethyl)-3-phenyl-2H-1,4-benzothiazine (SQ 11,579) under in vitro and in vivo conditions by rats, dogs, and monkey. Lan SJ; Chando TJ; Cohen AI; Weliky I; Schreiber EC Drug Metab Dispos; 1973; 1(4):619-27. PubMed ID: 4149635 [No Abstract] [Full Text] [Related]
7. Metabolic and pharmacokinetic study of bucloxic acid. I. Isolation and identification of the main excretion products in animals and in man. Gros PM; Davi HJ; Chasseaud LF; Hawkins DR Arzneimittelforschung; 1974 Sep; 24(9A SUPPL):1385-90. PubMed ID: 4480068 [No Abstract] [Full Text] [Related]
14. Physiologic disposition and metabolic fate of a new anti-inflammatory agent, cis-5-fluro-2-methyl-1-(p-(methylsulfinyl)-benzylidenyl)-indene-3-acetic acid in the rat, dog, rhesus monkey, and man. Hucker HB; Stauffer SC; White SD; Rhodes RE; Arison BH; Umbenhauer ER; Bower RJ; McMahon FG Drug Metab Dispos; 1973; 1(6):721-36. PubMed ID: 4156293 [No Abstract] [Full Text] [Related]
15. [Pharmacokinesic studies of BR 700, a drug with anti-inflammatory, analgesic and antipyretic activity]. Marmo E; Rossi F; Di Nola R; Gomarasca P Boll Chim Farm; 1973 Aug; 112(8):529-34. PubMed ID: 4770234 [No Abstract] [Full Text] [Related]
16. The disposition of butriptyline in rats, dogs and man. Cameron BD; Chasscaud LF; Lewis JD; Taylor T Arzneimittelforschung; 1974 Jan; 24(1):93-6. PubMed ID: 4406119 [No Abstract] [Full Text] [Related]
17. [Absorption of fenthiazac applied to the skin]. Pedrazzini S Boll Chim Farm; 1978 Jan; 117(1):19-26. PubMed ID: 743349 [No Abstract] [Full Text] [Related]
18. Distribution, excretion metabolism and localization of a new anti-inflammatory drug: niflumic acid, labelled with 14C. Glasson B; Benakis A; Strolin-Benedetti M Biochem Pharmacol; 1969 Mar; 18(3):633-43. PubMed ID: 5772593 [No Abstract] [Full Text] [Related]
19. [Absorption, distribution and excretion rate in diphenyldioxypyrazolidine drugs -14 C-kebuzon and 14 C- trimetazon- in rats]. Queisnerová M; Nĕmecek O Cesk Farm; 1971 Mar; 20(2):55-9. PubMed ID: 5550003 [No Abstract] [Full Text] [Related]